Your browser doesn't support javascript.
loading
An Erg-driven transcriptional program controls B cell lymphopoiesis.
Ng, Ashley P; Coughlan, Hannah D; Hediyeh-Zadeh, Soroor; Behrens, Kira; Johanson, Timothy M; Low, Michael Sze Yuan; Bell, Charles C; Gilan, Omer; Chan, Yih-Chih; Kueh, Andrew J; Boudier, Thomas; Feltham, Rebecca; Gabrielyan, Anna; DiRago, Ladina; Hyland, Craig D; Ierino, Helen; Mifsud, Sandra; Viney, Elizabeth; Willson, Tracy; Dawson, Mark A; Allan, Rhys S; Herold, Marco J; Rogers, Kelly; Tarlinton, David M; Smyth, Gordon K; Davis, Melissa J; Nutt, Stephen L; Alexander, Warren S.
Afiliación
  • Ng AP; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. ang@wehi.edu.au.
  • Coughlan HD; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia. ang@wehi.edu.au.
  • Hediyeh-Zadeh S; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Behrens K; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Johanson TM; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Low MSY; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Bell CC; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Gilan O; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Chan YC; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Kueh AJ; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Boudier T; Monash Haematology, Monash Hospital, Clayton, VIC, 3004, Australia.
  • Feltham R; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.
  • Gabrielyan A; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • DiRago L; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.
  • Hyland CD; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Ierino H; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.
  • Mifsud S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Viney E; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Willson T; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Dawson MA; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Allan RS; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Herold MJ; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.
  • Rogers K; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.
  • Tarlinton DM; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Smyth GK; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Davis MJ; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Nutt SL; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Alexander WS; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Nat Commun ; 11(1): 3013, 2020 06 15.
Article en En | MEDLINE | ID: mdl-32541654
ABSTRACT
B lymphoid development is initiated by the differentiation of hematopoietic stem cells into lineage committed progenitors, ultimately generating mature B cells. This highly regulated process generates clonal immunological diversity via recombination of immunoglobulin V, D and J gene segments. While several transcription factors that control B cell development and V(D)J recombination have been defined, how these processes are initiated and coordinated into a precise regulatory network remains poorly understood. Here, we show that the transcription factor ETS Related Gene (Erg) is essential for early B lymphoid differentiation. Erg initiates a transcriptional network involving the B cell lineage defining genes, Ebf1 and Pax5, which directly promotes expression of key genes involved in V(D)J recombination and formation of the B cell receptor. Complementation of Erg deficiency with a productively rearranged immunoglobulin gene rescued B lineage development, demonstrating that Erg is an essential and stage-specific regulator of the gene regulatory network controlling B lymphopoiesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Células Madre Hematopoyéticas / Linfocitos B / Diferenciación Celular / Proteínas Oncogénicas / Linfopoyesis / Regulador Transcripcional ERG Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Células Madre Hematopoyéticas / Linfocitos B / Diferenciación Celular / Proteínas Oncogénicas / Linfopoyesis / Regulador Transcripcional ERG Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Australia
...